Medicare Enrolled
Dr. Ian Storch, DO
Gastroenterology · New Hyde Park, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Storch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Storch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Storch
Dr. Ian Storch is a gastroenterology specialist in New Hyde Park, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Storch performed 3,565 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Storch received a total of $120,480 from 58 pharmaceutical and/or device companies across 739 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Storch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in NY
$120,480 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,565
Medicare services
Top 4% in NY for gastroenterology
Not available
Unique patients (not deduplicated)
$139
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
865 | $82 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
748 | $74 | $150 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
379 | $47 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
315 | $114 | $200 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
234 | $311 | $1,100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
191 | $95 | $275 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
152 | $121 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
117 | $147 | $300 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
104 | $334 | $1,200 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
99 | $248 | $1,400 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
75 | $722 | $2,000 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
73 | $437 | $1,700 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
35 | $50 | $66 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
35 | $346 | $1,100 |
| New patient office visit, complex (60-74 min) | 29 | $208 | $300 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
21 | $217 | $1,100 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
20 | $250 | $350 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
19 | $83 | $109 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
15 | $129 | $1,500 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $193 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $169 | $250 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
11 | $380 | $1,700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$120,480
Total received (2018-2024)
Avg $17,211/year across 7 years
Top 4% in NY for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
739
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,154
2023
$4,193
2022
$4,937
2021
$10,389
2020
$10,050
2019
$29,129
2018
$43,629
Payments by company (2024)
CapsoVision, Inc.
$15,958
ABBVIE INC.
$474
Janssen Biotech, Inc.
$244
PFIZER INC.
$188
IRONWOOD PHARMACEUTICALS, INC
$165
Phathom Pharmaceuticals, Inc.
$159
Takeda Pharmaceuticals U.S.A., Inc.
$156
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$119
Lilly USA, LLC
$89
Madrigal Pharmaceuticals
$83
Regeneron Healthcare Solutions, Inc.
$78
Amgen Inc.
$72
AstraZeneca Pharmaceuticals LP
$59
Ipsen Biopharmaceuticals, Inc
$50
Exact Sciences Corporation
$48
Ardelyx, Inc.
$42
Novo Nordisk Inc
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Celltrion USA Inc.
$24
GENZYME CORPORATION
$22
Medtronic, Inc.
$21
Intercept Pharmaceuticals, Inc.
$20
Intra-Sana Laboratories
$16
Top 3 companies account for 91.9% of 2024 payments
All-time payments by company (2018-2024) ›
CapsoVision, Inc.
$75,070
Merck Sharp & Dohme Corporation
$27,431
Amgen Inc.
$2,472
CapsoPro Services LLC
$2,400
AbbVie Inc.
$1,543
PENTAX of America, Inc.
$1,500
ABBVIE INC.
$1,231
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,099
AbbVie, Inc.
$1,039
Takeda Pharmaceuticals U.S.A., Inc.
$968
Janssen Biotech, Inc.
$560
RedHill Biopharma Inc.
$548
PFIZER INC.
$531
Ironwood Pharmaceuticals, Inc
$380
IRONWOOD PHARMACEUTICALS, INC
$339
Ardelyx, Inc.
$310
Regeneron Healthcare Solutions, Inc.
$268
Nestle HealthCare Nutrition Inc.
$227
Allergan Inc.
$189
Phathom Pharmaceuticals, Inc.
$182
Ferring Pharmaceuticals Inc.
$160
EVOKE PHARMA, INC.
$137
Gilead Sciences, Inc.
$125
Endo Pharmaceuticals Inc.
$116
GlaxoSmithKline, LLC.
$113
Lilly USA, LLC
$110
QOL Medical, LLC
$107
Evoke Pharma, Inc.
$95
Merck Sharp & Dohme LLC
$93
Concordia Pharmaceuticals Inc.
$90
Intercept Pharmaceuticals, Inc.
$84
AstraZeneca Pharmaceuticals LP
$83
Madrigal Pharmaceuticals
$83
Celgene Corporation
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Novo Nordisk Inc
$62
Ipsen Biopharmaceuticals, Inc
$50
Exact Sciences Corporation
$48
Shionogi Inc
$44
Medtronic, Inc.
$43
GENZYME CORPORATION
$42
Lundbeck LLC
$40
AIMMUNE THERAPEUTICS, INC.
$40
Janssen Pharmaceuticals, Inc
$36
Novartis Pharmaceuticals Corporation
$35
Celltrion USA Inc.
$24
Mylan Institutional Inc.
$23
Eisai Inc.
$22
Synergy Pharmaceuticals Inc
$19
Daiichi Sankyo Inc.
$19
Allergan, Inc.
$17
Intra-Sana Laboratories
$16
DERMIRA, INC.
$16
Boston Scientific Corporation
$15
IDORSIA PHARMACEUTICALS US INC
$13
Alfasigma USA, Inc.
$13
Napo Pharmaceuticals Inc
$11
Shire North American Group Inc
$11
Top 3 companies account for 87.1% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AMITIZA · APRISO · AVSOLA · BREZTRI · BYSTOLIC · C.A.P. HD Duodenoscope · CIMZIA · CLENPIQ · CREON · CYLTEZO · CapsoCam Colon · CapsoCam Plus · Cologuard Collection Kit · Creon · DIFICID · DONNATAL · DUPIXENT · Dayvigo · Donnatal · ENTRESTO · ENTYVIO · EOHILIA · Entyvio · GARDASIL 9 · GATTEX · GI GENIUS · GIMOTI · HUMIRA · Hulio · Humira · IBSRELA · INFLECTRA · INJECTAFER · INTERSTIM · INVOKANA · IQIRVO · JANUVIA · JARDIANCE · LEQVIO · LINZESS · LYNPARZA · Linzess · MAVYRET · MOTEGRITY · Mavyret · Mytesi · NASCOBAL · NOCDURNA · OCALIVA · OMVOH · PLENVU · QBREXZA · QUVIVIQ · RELTONE 200 MG · REMICADE · RENFLEXIS · RESMETIROM · REXULTI · RINVOQ · Repatha · SHINGRIX · SKYRIZI · STELARA · Sucraid · Symproic · TRELEGY ELLIPTA · TREMFYA · TRULANCE · Talicia · Trulance · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · WATCHMAN · Wegovy · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
1,149
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Storch is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Storch experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Storch performed 865 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Storch receive payments from pharmaceutical companies?
Yes. Dr. Storch received a total of $120,480 from 58 companies across 739 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Storch's costs compare to other gastroenterologists in New Hyde Park?
Dr. Storch's average Medicare payment per service is $139. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Storch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in New Hyde Park
Browse gastroenterologists in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NY
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NY
Which NY gastroenterologists receive the most from drug and device companies.
By company
CapsoVision, Inc. Payments to Doctors
See all physicians who received payments from CapsoVision, Inc.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology